Cetirizine Has No Approved Intramuscular Formulation
Cetirizine is not available or approved for intramuscular administration—it is exclusively formulated for oral use. 1
Available Routes and Formulations
- Cetirizine is FDA-approved only for oral administration as tablets, chewable tablets, and oral solution (syrup). 1
- The active ingredient is cetirizine HCl 5 mg per 5 mL in the oral solution formulation. 1
- No injectable (IM or IV) formulation of cetirizine exists in clinical practice. 1, 2, 3
Standard Oral Dosing for Allergic Conditions
Adults and Children ≥12 Years
- 5-10 mg once daily depending on symptom severity, with a maximum of 10 mg in 24 hours. 1
- Adults ≥65 years should receive 5 mg once daily (maximum 5 mg in 24 hours). 1
Children 6-12 Years
- 5-10 mg once daily depending on severity, with studies supporting 10 mg once daily as the most effective dose for seasonal allergic rhinitis. 4, 5, 6
- The 10 mg once-daily dose produced significantly greater symptom reduction than placebo in this age group. 4, 6
Children 2 to <6 Years
- 2.5 mg once daily, which can be increased to a maximum of 5 mg once daily or 2.5 mg every 12 hours if needed. 1
- Maximum dose is 5 mg in 24 hours. 1
Children <2 Years
- Consult a physician for appropriate dosing. 1
- Population pharmacokinetic studies support 0.25 mg/kg twice daily in infants 12-24 months, which achieves similar exposure to adult dosing. 7
Common Clinical Pitfall
Do not confuse cetirizine with chlorphenamine (chlorpheniramine), which does have an intramuscular formulation used in anaphylaxis management:
- Chlorphenamine IM/IV dosing: 10 mg for adults/children >12 years; 5 mg for ages 6-12 years; 2.5 mg for ages 6 months-6 years; 250 mcg/kg for <6 months. 8, 9
Role in Allergic Emergencies
- Cetirizine is not appropriate for acute anaphylaxis management, where intramuscular epinephrine is first-line therapy. 8, 10
- Antihistamines like cetirizine are second-line adjunctive therapy only and should never replace epinephrine in anaphylaxis. 8
- For emergency situations requiring parenteral antihistamine therapy, chlorphenamine or diphenhydramine (not cetirizine) should be used. 8, 9, 11
Renal and Hepatic Considerations for Oral Cetirizine
- Halve the oral dose in moderate renal impairment (creatinine clearance 10-20 mL/min). 8
- Avoid cetirizine in severe renal impairment (creatinine clearance <10 mL/min). 8
- Use with caution in hepatic impairment, though cetirizine is less hepatotoxic than first-generation antihistamines. 8
Clinical Efficacy Profile
- Cetirizine demonstrates rapid onset within 20 minutes and 24-hour duration of action for oral dosing. 3
- It is highly effective for seasonal allergic rhinitis, perennial allergic rhinitis, and chronic idiopathic urticaria. 2, 12
- Doubling the oral dose to 20 mg once daily may be effective in patients with urticaria refractory to standard 10 mg dosing. 13